Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients
Clinical trial NCT02530905 · COMPLETED
Trial details
- NCT number
- NCT02530905
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-08
- Primary completion
- 2018-10-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.